HAVEN REBECCA GARBER to Programmed Cell Death 1 Receptor
This is a "connection" page, showing publications HAVEN REBECCA GARBER has written about Programmed Cell Death 1 Receptor.
Connection Strength
0.034
-
Tumor Immune Microenvironment Changes by Multiplex Immunofluorescence Staining in a Pilot Study of Neoadjuvant Talazoparib for Early-Stage Breast Cancer Patients with a Hereditary BRCA Mutation. Clin Cancer Res. 2022 09 01; 28(17):3669-3676.
Score: 0.034